drugset

drugset / Trial / NCT00255281

Efficacy and Safety of AZD7009 in the Treatment of Atrial Fibrillation

NCT00255281 ↗

Phase 2 Completed 160 enrolled AstraZeneca

RandomizedParallel-groupDouble-blindTreatment

Summary

The current study is designed to assess the efficacy and safety of iv AZD7009 in conversion from AF

Timeline

Start: 2005-09
Primary completion: —
Completion: 2006-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	AZD7009	Small molecule	—	Intravenous

Indications